Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 4, 2007
Patent Application Number
10493070
Date Filed
November 1, 2002
Patent Primary Examiner
Patent abstract
A preventive and/or therapeutic agent for post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening, wherein the agent contains, as an active ingredient, a monocyte chemoattractant protein-1 (MCP-1) function inhibitor. Administration of the MCP-1 function inhibitor enables prevention and treatment of post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.